SCHEMBL12268385

SCHEMBL12268385

COC(=O)/C(=C\C=C\N(C)CCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C)S(=O)(=O)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MAPK1 P28482 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ NR1I2 O75469 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13556970 0.93 ALDH1A1 (0.32) ALDH1A1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL12268345 0.91 LMNA (0.32) SMN1; SMN2LMNAMAPT
SCHEMBL14416555 0.90 ALDH1A1 (0.36) ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1
SCHEMBL13988609 0.89 ALDH1A1 (0.33) ALDH1A1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL12268367 0.88 — —
SCHEMBL12268627 0.82 ALDH1A1 (0.34) ALDH1A1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL13609928 0.80 ALDH1A1 (0.42) ALDH1A1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL12381965 0.78 ALDH1A1 (0.32) ALDH1A1KMT2ASMN1; SMN2RAB9AMAPK1
SCHEMBL13609923 0.77 ALDH1A1 (0.48) ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1
SCHEMBL805450 0.77 ALDH1A1 (0.48) ALDH1A1KMT2ASMN1; SMN2RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120269749-A1 COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A MEROCYANIN SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A MEROCYANIN SCREENING AGENT L'OREAL (FR) 2012-10-25 — — US disclosed
US-8025867-B2 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds L'OREAL (FR) 2011-09-27 — — US disclosed
US-20080305058-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds L'OREAL (FR) 2008-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120269749-A1 COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A MEROCYANIN SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A MEROCYANIN SCREENING AGENT PYCR1, TYR, PAH ALDH1A1 661/4885KMT2A 1933/4885SMN1; SMN2 4579/4885
US-20080305058-A1 Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and merocyanine sulfone compounds DDT, DSG1, DSC1 ALDH1A1 809/4885KMT2A 1436/4885SMN1; SMN2 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback